00000nam 2200000zi 4500 9.689808 CaOODSP 20221107134454 m o d f cr cn||||||||| 150407s2007 onca ob f000 0 eng d 9780662458883 9780662698272 (incorrect) CaOODSP eng rda CaOODSP n-cn--- H79-1/2007E-PDF H79-1/2007 Budget impact analysis guidelines : guidelines for conducting pharmaceutical budget impact analyses for submission to public drug plans in Canada. Guidelines for conducting pharmaceutical budget impact analyses for submission to public drug plans in Canada [First edition]. [Ottawa] : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, 2007. 1 online resource (i, 58 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Lignes directrices pour l'analyse de l'incidence du prix d'un médicament : lignes directrices pour l'analyse de l'incidence du prix d'un médicament sur les budgets des régimes d'assurance-médicaments. "Published May 2007." Includes bibliographical references (pages 56-58). 10-03-Supp 2010-06-21 Drugs Prices Canada. Drugs Economic aspects Canada. Pharmaceutical services insurance Canada. Canada. Patented Medicine Prices Review Board. Lignes directrices pour l'analyse de l'incidence du prix d'un médicament : (CaOODSP)9.634205 Budget impact analysis guidelines : (CaOODSP)9.885893 http://publications.gc.ca PDF 621 KB https://publications.gc.ca/collections/collection_2008/hc-sc/H79-1-2007E.pdf